SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CareMax, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Monday, 3/18/24, at 6:51am ET   ·   For:  12/31/23   ·   Accession #:  950170-24-32506   ·   File #:  1-39391

Previous ‘10-K’:  ‘10-K’ on 3/30/23 for 12/31/22   ·   Next & Latest:  ‘10-K/A’ on 4/29/24 for 12/31/23   ·   17 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/24  CareMax, Inc.                     10-K       12/31/23  105:13M                                    Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.39M 
 2: EX-21.1     Subsidiaries List                                   HTML     35K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     31K 
 8: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     44K 
                Awarded Compensation                                             
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
10: R1          Document and Entity Information                     HTML    113K 
11: R2          Consolidated Balance Sheets                         HTML    139K 
12: R3          Consolidated Balance Sheets (Parenthetical)         HTML     52K 
13: R4          Consolidated Statements of Operations               HTML    122K 
14: R5          Consolidated Statements of Operations               HTML     32K 
                (Parenthetical)                                                  
15: R6          Consolidated Statements of Changes in Stockholders  HTML     76K 
                Equity                                                           
16: R7          Consolidated Statements of Changes in               HTML     32K 
                Stockholders' Equity (Parenthetical)                             
17: R8          Consolidated Statements of Cash Flows               HTML    160K 
18: R9          Description of Business and Going Concern           HTML     49K 
19: R10         Summary of Significant Accounting Policies          HTML    123K 
20: R11         Accounts Receivable                                 HTML     91K 
21: R12         Acquisitions                                        HTML     97K 
22: R13         Reinsurance                                         HTML     38K 
23: R14         Goodwill and Other Intangible Assets                HTML    125K 
24: R15         Property and Equipment                              HTML     60K 
25: R16         Debt and Related Party Debt                         HTML     91K 
26: R17         Stockholders' Equity                                HTML     72K 
27: R18         Stock-Based Compensation                            HTML    118K 
28: R19         Net Loss Per Share                                  HTML     75K 
29: R20         Fair Value Measurements                             HTML    169K 
30: R21         Related Party Transactions                          HTML     56K 
31: R22         Leases                                              HTML    113K 
32: R23         Income Taxes                                        HTML    123K 
33: R24         Commitments and Contingencies                       HTML     36K 
34: R25         Variable Interest Entities                          HTML     53K 
35: R26         Subsequent Events                                   HTML     37K 
36: R27         Summary of Significant Accounting Policies          HTML    175K 
                (Policies)                                                       
37: R28         Summary of Significant Accounting Policies          HTML     36K 
                (Tables)                                                         
38: R29         Accounts Receivable (Tables)                        HTML     94K 
39: R30         Acquisitions (Tables)                               HTML     85K 
40: R31         Goodwill and Other Intangible Assets (Tables)       HTML    127K 
41: R32         Property and Equipment (Tables)                     HTML     57K 
42: R33         Debt and Related Party Debt (Tables)                HTML     71K 
43: R34         Stock-Based Compensation (Tables)                   HTML    108K 
44: R35         Net Loss Per Share (Tables)                         HTML     75K 
45: R36         Fair Value Measurements (Tables)                    HTML    155K 
46: R37         Leases (Tables)                                     HTML    113K 
47: R38         Income Taxes (Tables)                               HTML    117K 
48: R39         Variable Interest Entities (Tables)                 HTML     51K 
49: R40         Description of Business and Going Concern -         HTML     71K 
                Additional Information (Details)                                 
50: R41         Summary of Significant Accounting Policies -        HTML     80K 
                Additional Information (Details)                                 
51: R42         Summary of Significant Accounting Policies -        HTML     50K 
                Summary of Estimated Useful Lives of Property and                
                Equipment (Details)                                              
52: R43         Accounts Receivable - Schedule of Accounts          HTML     44K 
                Receivable Net, and Risk Settlement Liabilities                  
                (Details)                                                        
53: R44         Accounts Receivable - Summary of Changes            HTML     44K 
                Recognized in Prior Year Estimates (Details)                     
54: R45         Accounts Receivable - Schedule of Revenues and      HTML     52K 
                Accounts Receivable Balances for Payors Comprising               
                10% or More of Revenue (Details)                                 
55: R46         Acquisitions - Additional Information (Details)     HTML     88K 
56: R47         Acquisitions - Summary of Purchase Consideration    HTML     49K 
                (Details)                                                        
57: R48         Acquisitions - Summary of Purchase Consideration    HTML     46K 
                (Parenthetical) (Details)                                        
58: R49         Acquisitions - Summary of Initial and Final Fair    HTML     68K 
                Value of Assets Acquired and Liabilities Assumed                 
                (Details)                                                        
59: R50         Acquisitions - Summary of Unaudited Pro-Forma       HTML     36K 
                Information (Details)                                            
60: R51         Reinsurance - Additional Information (Details)      HTML     39K 
61: R52         Goodwill and Other Intangible Assets - Summary of   HTML     42K 
                Changes in Carrying Amount of Goodwill (Details)                 
62: R53         Goodwill and Other Intangible Assets - Summary of   HTML     56K 
                Gross Carrying Amount and Accumulated Amortization               
                of Intangible Assets by Major Class (Details)                    
63: R54         Goodwill and Other Intangible Assets - Additional   HTML     42K 
                Information (Details)                                            
64: R55         Goodwill and Other Intangible Assets - Schedule of  HTML     46K 
                Estimated Amortization for Intangible Assets                     
                (Details)                                                        
65: R56         Property and Equipment - Summary of Property and    HTML     55K 
                Equipment (Details)                                              
66: R57         Property and Equipment - Summary of Property and    HTML     32K 
                Equipment (Parenthetical) (Details)                              
67: R58         Property and Equipment - Additional Information     HTML     33K 
                (Details)                                                        
68: R59         Debt and Related Party Debt - Summary of Debt       HTML     59K 
                (Details)                                                        
69: R60         Debt and Related Party Debt - Summary of Debt       HTML     40K 
                (Parenthetical) (Details)                                        
70: R61         Debt and Related Party Debt - Additional            HTML    124K 
                Information (Details)                                            
71: R62         Debt and Related Party Debt - Summary of Future     HTML     50K 
                Maturities of Debt Outstanding (Details)                         
72: R63         Stockholders' Equity - Additional information       HTML     90K 
                (Details)                                                        
73: R64         Stockholders' Equity - Redeemable Warrants          HTML     47K 
                (Details)                                                        
74: R65         Stockholders' Equity - Contingent Consideration     HTML     71K 
                (Details)                                                        
75: R66         Stock-Based Compensation - Additional Information   HTML     70K 
                (Details)                                                        
76: R67         Stock-Based Compensation - Summary of RSUs          HTML     60K 
                Activity (Details)                                               
77: R68         Stock-Based Compensation - Summary of PSUs          HTML     55K 
                Activity (Details)                                               
78: R69         Stock-Based Compensation - Assumptions Used to      HTML     51K 
                Calculate Fair Value of PSUs (Details)                           
79: R70         Stock-Based Compensation - Summary of Options       HTML     43K 
                Activity (Details)                                               
80: R71         Stock-Based Compensation - Assumptions Used to      HTML     50K 
                Calculate Fair Value of Options (Details)                        
81: R72         Net Loss Per Share - Summary of Calculation of      HTML     61K 
                Basic and Diluted Net Loss Per Share (Details)                   
82: R73         Net Loss Per Share - Potentially Dilutive           HTML     48K 
                Outstanding Securities Excluded from Computation                 
                of Diluted Net Loss Per Share (Details)                          
83: R74         Net Loss Per Share - Potentially Dilutive           HTML     34K 
                Outstanding Securities Excluded from Computation                 
                of Diluted Net Loss Per Share (Parenthetical)                    
                (Details)                                                        
84: R75         Fair Value Measurements - Schedule of Assets and    HTML     49K 
                Liabilities Measured at Fair Value on Recurring                  
                Basis (Details)                                                  
85: R76         Fair Value Measurements - Additional Information    HTML     53K 
                (Details)                                                        
86: R77         Fair Value Measurements - Schedule of Quantitative  HTML     49K 
                Information of Level 3 Fair Value Measurements                   
                Inputs (Details)                                                 
87: R78         Fair Value Measurements - Schedule of Activity of   HTML     40K 
                the Level 3 Liabilities Measured at Fair Value                   
                (Details)                                                        
88: R79         Fair Value Measurements - Schedule of Measured at   HTML     45K 
                Fair Value on Nonrecurring Basis (Details)                       
89: R80         Related Party Transactions - Additional             HTML     79K 
                Information (Details)                                            
90: R81         Leases - Additional Information (Details)           HTML     53K 
91: R82         Leases - Location of Finance Lease Right-of-use     HTML     39K 
                Assets and Lease Liabilities in Company's                        
                Consolidated Balance Sheet (Details)s                            
92: R83         Leases - Schedule of Lease Costs (Details)          HTML     45K 
93: R84         Leases - Schedule of Maturities of Operating and    HTML     70K 
                Finance Lease Liabilities (Details)                              
94: R85         Leases - Schedule of Other Information Related to   HTML     47K 
                Lease Agreements (Details)                                       
95: R86         Income Taxes - Components of Income Tax Benefit     HTML     43K 
                (Details)                                                        
96: R87         Income Taxes - Summary of Reconciliation Between    HTML     49K 
                Effective Tax Rate (Details)                                     
97: R88         Income Taxes - Summary of Deferred Tax Assets and   HTML     63K 
                Liabilities (Details)                                            
98: R89         Income Taxes - Additional Information (Details)     HTML     56K 
99: R90         Variable Interest Entities - Schedule of Assets     HTML     63K 
                and liabilities of PCs and Care Optical (Details)                
100: R91         Subsequent Events - Additional Information          HTML     40K  
                (Details)                                                        
102: XML         IDEA XML File -- Filing Summary                      XML    201K  
105: XML         XBRL Instance -- cmax-20231231_htm                   XML   2.90M  
101: EXCEL       IDEA Workbook of Financial Report Info              XLSX    216K  
 9: EX-101.SCH  XBRL Taxonomy Extension Schema With Embedded         XSD   5.37M 
                Linkbases Document -- cmax-20231231                              
103: JSON        XBRL Instance as JSON Data -- MetaLinks              665±  1.07M  
104: ZIP         XBRL Zipped Folder -- 0000950170-24-032506-xbrl      Zip    718K  


‘EX-97.1’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-97.1  

Exhibit 97.1

 

CAREMAX, INC.

POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION

 

Introduction

 

The Board of Directors (the “Board”) of CareMax, Inc. (the “Company”) has adopted this Policy on Recoupment of Incentive Compensation (this “Policy”), which provides for the recoupment of compensation in certain circumstances in the event of a restatement of financial results by the Company. This Policy shall be interpreted to comply with the requirements of U.S. Securities and Exchange Commission (“SEC”) rules and Nasdaq Stock Market (“Nasdaq”) listing standards implementing Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) and, to the extent this Policy is in any manner deemed inconsistent with such rules, this Policy shall be treated as retroactively amended to be compliant with such rules.

 

Administration

 

This Policy shall be administered by the Compensation Committee (the “Compensation Committee”) of the Board. Any determinations made by the Compensation Committee shall be final and binding on all affected individuals. The Compensation Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate or advisable for the administration of this Policy, in all cases consistent with the Dodd-Frank Act. The Board or Compensation Committee may amend this Policy from time to time in its discretion.

 

Covered Executives

 

This Policy applies to any current or former “executive officer,” within the meaning of Rule 10D-1 under the Securities Exchange Act of 1934, as amended, of the Company or a subsidiary of the Company (each such individual, an “Executive”). This Policy shall be binding and enforceable against all Executives and their beneficiaries, executors, administrators, and other legal representatives.

 

Recoupment Upon Financial Restatement

 

If the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a “Financial Restatement”), the Compensation Committee shall cause the Company to recoup from each Executive, as promptly as reasonably possible, any erroneously awarded Incentive-Based Compensation, as defined below.

 

No-Fault Recovery

 

Recoupment under this Policy shall be required regardless of whether the Executive or any other person was at fault or responsible for accounting errors that contributed to the need for the Financial Restatement or engaged in any misconduct.

 

Compensation Subject to Recovery; Enforcement

 

This Policy applies to all compensation granted, earned or vested based wholly or in part upon the attainment of any financial reporting measure determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measure that is derived wholly or in part from such measures, whether or not presented within the Company’s financial statements or included in a filing with the SEC, including stock price and total shareholder return (“TSR”), including but not limited to performance-based cash, stock, options or other equity-based awards paid or granted to the Executive (“Incentive-Based Compensation”). Compensation that is granted, vests or is earned based solely upon the occurrence of non-financial events, such as base salary, restricted stock or options with time-based vesting, or a bonus awarded solely at the discretion of the Board or Compensation Committee and not based on the attainment of any financial measure, is not subject to this Policy.

 

In the event of a Financial Restatement, the amount to be recovered will be the excess of (i) the Incentive-Based Compensation received by the Executive during the Recovery Period (as defined below) based on the erroneous data and calculated without regard to any taxes paid or withheld, over (ii) the Incentive-Based Compensation that would have been received by the Executive had it been calculated based on the restated financial information, as determined by the Compensation Committee. For purposes of this Policy, “Recovery Period” means the three completed fiscal years immediately preceding the date on which the Company is required to prepare the Financial Restatement, as determined in accordance with the last sentence of this paragraph, or any transition period that results from a change in the Company’s fiscal year (as set forth in Section 5608(b)(i)(D) of the Nasdaq Listing Rules). The date on which the Company is required to prepare a Financial Restatement is the earlier to occur of (A) the date the Board or a Board committee (or authorized officers of the Company if Board action is not required) concludes, or reasonably should have concluded, that the Company is required


to prepare a Financial Restatement or (B) the date a court, regulator, or other legally authorized body directs the Company to prepare a Financial Restatement.

For Incentive-Based Compensation based on stock price or TSR, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement, then the Compensation Committee shall determine the amount to be recovered based on a reasonable estimate of the effect of the Financial Restatement on the stock price or TSR upon which the Incentive-Based Compensation was received and the Company shall document the determination of that estimate and provide it to Nasdaq.

 

Incentive-Based Compensation is considered to have been received by an Executive in the fiscal year during which the applicable financial reporting measure was attained or purportedly attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period.

 

The Company may use any legal or equitable remedies that are available to the Company to recoup any erroneously awarded Incentive-Based Compensation, including but not limited to by collecting from the Executive cash payments or shares of Company common stock from or by forfeiting any amounts that the Company owes to the Executive. Executives shall be solely responsible for any tax consequences to them that result from the recoupment or recovery of any amount pursuant to this Policy, and the Company shall have no obligation to administer the Policy in a manner that avoids or minimizes any such tax consequences.

 

No Indemnification

 

The Company shall not indemnify any Executive or pay or reimburse the premium for any insurance policy to cover any losses incurred by such Executive under this Policy or any claims relating to the Company’s enforcement of rights under this Policy.

 

Exceptions

 

The compensation recouped under this Policy shall not include Incentive-Based Compensation received by an Executive (i) prior to beginning service as an Executive or (ii) if he or she did not serve as an Executive at any time during the performance period applicable to the Incentive-Based Compensation in question. The Compensation Committee (or a majority of independent directors serving on the Board) may determine not to seek recovery from an Executive in whole or part to the extent it determines in its sole discretion that such recovery would be impracticable because (A) the direct expense paid to a third party to assist in enforcing recovery would exceed the recoverable amount (after having made a reasonable attempt to recover the erroneously awarded Incentive-Based Compensation and providing corresponding documentation of such attempt to Nasdaq), (B) recovery would violate the home country law that was adopted prior to November 28, 2022, as determined by an opinion of counsel licensed in the applicable jurisdiction that is acceptable to and provided to Nasdaq, or (C) recovery would likely cause the Company’s 401(k) plan or any other tax-qualified retirement plan to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and the regulations thereunder.

 

Other Remedies Not Precluded

 

The exercise by the Compensation Committee of any rights pursuant to this Policy shall be without prejudice to any other rights or remedies that the Company, the Board or the Compensation Committee may have with respect to any Executive subject to this Policy, whether arising under applicable law (including pursuant to Section 304 of the Sarbanes-Oxley Act of 2002), regulation or pursuant to the terms of any other policy of the Company, employment agreement, equity award, cash incentive award or other agreement applicable to an Executive. Notwithstanding the foregoing, there shall be no duplication of recovery of the same Incentive-Based Compensation under this Policy and any other such rights or remedies.

 

Acknowledgment

 

To the extent required by the Compensation Committee, each Executive shall be required to sign and return to the Company the acknowledgement form attached hereto as Exhibit A pursuant to which such Executive will agree to be bound by the terms of, and comply with, this Policy. For the avoidance of doubt, each Executive shall be fully bound by, and must comply with, the Policy, whether or not such Executive has executed and returned such acknowledgment form to the Company.

 

Effective Date and Applicability

 

This Policy has been adopted by the Board on November 28, 2023, and shall apply to any Incentive-Based Compensation that is received by an Executive on or after October 2, 2023.

 

 

 

 

 


 

 

EXHIBIT A

 

DODD-FRANK COMPENSATION CLAWBACK POLICY

 

ACKNOWLEDGEMENT FORM

 

Capitalized terms used but not otherwise defined in this Acknowledgement Form (this “Acknowledgement Form”) shall have the meanings ascribed to such terms in the Policy.

 

By signing this Acknowledgement Form, the undersigned acknowledges, confirms and agrees that the undersigned: (i) has received and reviewed a copy of the Policy; (ii) is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned’s employment with the Company; and (iii) will abide by the terms of the Policy, including, without limitation, by reasonably promptly returning any recoverable compensation to the Company as required by the Policy, as determined by the Compensation Committee in its sole discretion.

 

 

 

 

 

 

 

Sign: _____________________________

Name: [Employee]

 

 

Date: _____________________________



Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/18/24None on these Dates
For Period end:12/31/23
11/28/23
10/2/23
11/28/22
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/24  CareMax, Inc.                     10-K/A     12/31/23   10:3.3M                                   Donnelley … Solutions/FA


16 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/05/24  CareMax, Inc.                     8-K:3,5,9   1/31/24    9:456K                                   Donnelley … Solutions/FA
 5/10/23  CareMax, Inc.                     10-Q        3/31/23   86:14M                                    Donnelley … Solutions/FA
 3/30/23  CareMax, Inc.                     10-K       12/31/22  102:18M                                    Donnelley … Solutions/FA
11/14/22  CareMax, Inc.                     8-K:1,2,3,711/10/22   18:1.1M                                   Donnelley … Solutions/FA
 6/01/22  CareMax, Inc.                     8-K:1,7,9   5/31/22   15:5.1M                                   Donnelley … Solutions/FA
 1/05/22  CareMax, Inc.                     8-K:1,9    12/30/21   12:2M                                     Donnelley … Solutions/FA
12/17/21  CareMax, Inc.                     8-K:5,9    12/13/21   14:851K                                   Donnelley … Solutions/FA
10/25/21  CareMax, Inc.                     S-8        10/25/21    9:561K                                   ActiveDisclosure/FA
10/06/21  CareMax, Inc.                     8-K:5,9     9/30/21   12:331K                                   Donnelley … Solutions/FA
 7/13/21  CareMax, Inc.                     8-K:1,3,5,7 7/13/21   14:12M                                    Toppan Merrill/FA
 7/07/21  CareMax, Inc.                     8-K:1,7,9   7/05/21   13:980K                                   Toppan Merrill/FA
 6/21/21  CareMax, Inc.                     8-K:2,3,7,9 6/18/21   13:639K                                   Toppan Merrill/FA
 6/14/21  CareMax, Inc.                     8-K:1,2,3,5 6/08/21   22:4.8M                                   Toppan Merrill/FA
 6/09/21  CareMax, Inc.                     8-A12B/A               7:433K                                   Toppan Merrill/FA
12/21/20  CareMax, Inc.                     8-K/A:7,9  12/18/20    8:1.7M                                   Toppan Merrill/FA
 7/21/20  CareMax, Inc.                     8-K:1,3,5,8 7/16/20   13:943K                                   Toppan Merrill/FA
Top
Filing Submission 0000950170-24-032506   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 12:13:43.2pm ET